Literature DB >> 25273139

Pollen Typhae total flavone improves insulin resistance in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats.

Xiao-Tao Feng1, Qun Chen, Zhen Xie, Xiao Liang, Ze-Hui Jiang, Wei Zhao, Jing Leng.   

Abstract

Pollen Typhae total flavone (PTF), the extract from Pollen Typhae, is reported to enhance glucose uptake in C2C12 myotubes in vitro, but the convincing evidence is lacking in vivo. In this study, PTF ameliorated insulin resistance and dyslipidemia, but failed to significantly increase body weight in type 2 diabetic rats induced by high-fat diet and low-dose streptozotocin.

Entities:  

Keywords:  dyslipidemia; glucose tolerance; insulin resistance; traditional Chinese medicine; type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25273139     DOI: 10.1080/09168451.2014.930318

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Tert-Butylhydroquinone alleviates insulin resistance and liver steatosis in diabetes.

Authors:  Tian-Tian Zhu; Chao-Nan Zhu; Ning Huang; Xin Yu; Guang-Rui Wan; Shuang-Xi Wang; Ping Song; Jian Xu; Peng Li; Ya-Ling Yin
Journal:  Indian J Pharmacol       Date:  2022 Mar-Apr       Impact factor: 2.833

2.  Effects of Extracts from Tiaozhi Granule and Its Components on Expression of Scavenger Receptor Class B Type I.

Authors:  Xiao Yu; Xiao-Dong Zhao; Rong-Qi Bao; Jia-Yu Yu; Guo-Xing Zhang; Jing-Wei Chen
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-06       Impact factor: 2.629

3.  Investigating the Mechanisms of Pollen Typhae in the Treatment of Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking.

Authors:  Rongrong Zhou; Yuqing Zhang; Liyun Duan; Yuehong Zhang; Yingying Duan; Xiaomin Kang; Fengmei Lian
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-03       Impact factor: 2.629

4.  Effects of Tiaozhi Granule on Regulation of Autophagy Levels in HUVECs.

Authors:  Ying-Ying Wu; Chao Chen; Xiao Yu; Xiao-Dong Zhao; Rong-Qi Bao; Jia-Yu Yu; Guo-Xing Zhang; Jing-Wei Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-12       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.